In the context of cancer, study also has shown that oral cancer patients undergoing ICB therapy not only experience an expansion of local tumor‐specific CD8+TRM cells but also an increase in activated T cells with the same clonotypes detected in the bloodstream [30]. The gene discussed is CD8A; the disease is cancer.